https://www.sciencedaily.com/releases/2025/07/250715043353.htm
0
0
7/15/25 at 1:26pm
Organization
Science Daily
54 words
0
Comments
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors. University of Michigan researchers found mice lost about 20…
You are the first to view
Create an account
or login to join the discussion